DONNA DELFIN: Open Payments
NPI 1477718740 · BROOMALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 53 payments from 18 companies in 2025. Trend: 2023 $1,254 · 2024 $2,429 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $239 |
| PFIZER INC. | 10 | $191 |
| Novo Nordisk Inc | 5 | $114 |
| Eisai Inc. | 1 | $74 |
| Exact Sciences Corporation | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Astellas Pharma US Inc | 2 | $45 |
| Bausch Health US, LLC | 2 | $39 |
| Abbott Laboratories | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
Products named: VRAYLAR, Wegovy, QULIPTA, Leqembi, The Cologuard Plus Collection Kit, NURTEC ODT, PAXLOVID, Veozah.
Industry payments across PA — which companies pay providers there.
